Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ray Kim

Showing results (61-70 of 248) with videos related to

Pageof 25
Sort By:
JHEP Reports : Innovation in Hepatology|September 18, 2024
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE scorePimsiri Sripongpun, Apichat Kaewdech, Prowpanga Udompap, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2019
Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide ProphylaxisPimsiri Sripongpun, Ajitha Mannalithara, Paul Y Kwo, et al.
Hepatology (Baltimore, Md.)|July 1, 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision MedicineGeorge V Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Improved posttransplant mortality after share 35 for liver transplantationAllison J Kwong, Aparna Goel, Ajitha Mannalithara, et al.
Transplantation Direct|June 17, 2024
The Future Frontier of Liver Transplantation Exploring Young Donor Allocation Strategies for HCC RecipientsMiho Akabane, Carlos O Esquivel, W Ray Kim, et al.
The Journal of Family Practice|April 30, 2002
Diagnosis and 10-year follow-up of a community-based hepatitis C cohortBarbara P Yawn, Peter Wollan, Liliana Gazzuola, et al.
Nephron. Clinical Practice|June 17, 2011
Treatment of hepatitis B virus-associated nephropathyUsama Elewa, Ana Maria Sandri, W Ray Kim, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United StatesDonghee Kim, W Ray Kim, Hwa Jung Kim, et al.
Journal of Hepatology|November 19, 2022
Response to: "Towards optimally replacing the current version of MELD"Jin Ge, W Ray Kim, Jennifer C Lai, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 24, 2007
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver diseaseCharmaine A Stewart, Michael Malinchoc, W Ray Kim, et al.
Pageof 25

Showing results (61-70 of 248) with videos related to

Sort By:
Pageof 25
JHEP Reports : Innovation in Hepatology|September 18, 2024
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE scorePimsiri Sripongpun, Apichat Kaewdech, Prowpanga Udompap, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2019
Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide ProphylaxisPimsiri Sripongpun, Ajitha Mannalithara, Paul Y Kwo, et al.
Hepatology (Baltimore, Md.)|July 1, 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision MedicineGeorge V Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Improved posttransplant mortality after share 35 for liver transplantationAllison J Kwong, Aparna Goel, Ajitha Mannalithara, et al.
Transplantation Direct|June 17, 2024
The Future Frontier of Liver Transplantation Exploring Young Donor Allocation Strategies for HCC RecipientsMiho Akabane, Carlos O Esquivel, W Ray Kim, et al.
The Journal of Family Practice|April 30, 2002
Diagnosis and 10-year follow-up of a community-based hepatitis C cohortBarbara P Yawn, Peter Wollan, Liliana Gazzuola, et al.
Nephron. Clinical Practice|June 17, 2011
Treatment of hepatitis B virus-associated nephropathyUsama Elewa, Ana Maria Sandri, W Ray Kim, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United StatesDonghee Kim, W Ray Kim, Hwa Jung Kim, et al.
Journal of Hepatology|November 19, 2022
Response to: "Towards optimally replacing the current version of MELD"Jin Ge, W Ray Kim, Jennifer C Lai, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 24, 2007
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver diseaseCharmaine A Stewart, Michael Malinchoc, W Ray Kim, et al.
Pageof 25